GlaxoSmithKline Pharmaceuticals · NSE: GLAXO · BSE: 500660
Q3 FY19 results · Oct–Dec 2018
GlaxoSmithKline Pharmaceuticals reported revenue from operations of ₹825.35 crore and net profit of ₹112.97 crore for Q3 FY19 (Oct–Dec 2018), on a standalone basis.
| Item | Q3 FY19 | Q3 FY18 | YoY | Q2 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 825.35 | — | — | 816.31 | +1.1% |
| Other income | 16.42 | — | — | 14.82 | +10.8% |
| Total income | 841.77 | — | — | 831.13 | +1.3% |
| Profit before tax | 169.78 | — | — | 156.46 | +8.5% |
| Net profit for the period | 112.97 | — | — | 100.77 | +12.1% |
| EPS, basic (₹) | 6.67 | — | — | 5.95 | +12.1% |
| Net margin (%) | 13.7 | — | 12.3 |
Standalone
- Filed with BSE
- 04 Feb 2019, 17:45 IST
- Board meeting
- 04 Feb 2019
- Period
- 01 Oct 2018 to 31 Dec 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE